Intrasphincteric botulinum toxin for the treatment of achalasia.
about
Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trialsEndoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasiaEndoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasiaEndoscopic balloon dilatation versus botulinum toxin injection in the management of primary achalasiaTissue engineering for neuromuscular disorders of the gastrointestinal tractTreatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment.Pharmacotherapy for the management of achalasia: Current status, challenges and future directionsData analyses and perspectives on laparoscopic surgery for esophageal achalasiaIdiopathic (primary) achalasia: a reviewRecent trends in endoscopic management of achalasiaNew insights into the pathophysiology of achalasia and implications for future treatmentManagement of primary achalasia: The role of endoscopyIntrasphincteric botulinum toxin injection in treatment of chronic idiopathic constipation in children.Association between gastroesophageal reflux disease after pneumatic balloon dilatation and clinical course in patients with achalasia.Botulinum toxin: potent poison, potent medicine.Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxinThe cosmetic uses of Botulinum toxin type A.Review article: pharmacological options in achalasia.Esophageal pharmacology and treatment of primary motility disorders.Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.Receptors of the enteric nervous system: potential targets for drug therapy.Current approach to the treatment of achalasia.2011 update on esophageal achalasia.Endoscopic approaches to treatment of achalasiaRisk factors of oesophageal perforation during pneumatic dilatation for achalasia.Difficult myotomy is not determined by preoperative therapy and does not impact outcome.Review article: the management of achalasia - a comparison of different treatment modalities.Idiopathic (primary) achalasia.Long term results of pneumatic dilation in achalasia followed for more than 5 years.Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?Concepts in pathogenesis and treatment of chronic anal fissure--a review of the literature.Review article: botulinum toxin in the therapy of gastrointestinal motility disorders.Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trialA multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.Cost-assessment of alternative management strategies for achalasia.Effect of peroral esophageal myotomy for achalasia treatment: A Chinese study.Use of Clostridium botulinum toxin in gastrointestinal motility disorders in childrenReview article: the management of pelvic floor disorders.Treatment of achalasia in the era of high-resolution manometry.Botulinum toxin in clinical practice
P2860
Q21245273-971D9E4D-A912-460D-B5BA-7B90812BFF15Q24187420-6700A220-CDF3-4263-B765-B977320E0BFCQ24243791-362F6779-A679-431C-B776-0D50FE9FAFC6Q24246467-D6DDC41A-3B13-4BC2-9986-FFF734AB6305Q24594791-C2B64CD4-6C10-4225-947A-B1D75DA7A8E9Q24799447-F8D5020A-A4CA-4E6F-9518-707B0ACCAD35Q26777632-D6711DD6-2463-4BF4-BA81-EA7A4B6D5E2FQ26781982-3A4D660B-EA04-42A8-A772-C1E15B832EC4Q26801313-10720C20-073B-4038-8DCA-4726379EBD9EQ26865445-724512C9-A2E1-45B7-9240-EBB4FB8A4AF1Q28068914-D53EA103-A8F3-4B80-8ABF-CE4856A5F8F9Q28083770-5E86458A-5F37-42CE-ADDB-88A6DD7024D3Q33552107-91889790-5C72-44B3-9AF8-F2687CA4A7E3Q33586792-8FCF401C-3551-4753-BE35-62B1A89257F7Q33599191-CC361F14-7C5A-41FE-9FBD-11952316A9EAQ33618302-6ACF9336-90B7-4491-9A9A-9C25675231F5Q33750159-F6E47792-6221-4CBA-8382-B9CF759CB84FQ33778807-19E952E5-B264-4B85-9A48-792C614A3BA3Q33894383-3C1C0A1F-2EC7-403E-A438-EDA5F472D7E6Q34041378-02E11E6F-AA71-41CE-AED8-EA1C9A1391C3Q34081740-27FBB385-F06A-444C-A122-14C0A90B57D3Q34172430-3AF4CC62-15CB-49F3-A7C6-FB54281784A2Q34270601-B3A1BB33-27F6-4581-821E-D6938DB099ADQ34333494-7ACD7F12-C98D-4D85-BDDE-EBBFB515A550Q34409887-3B22031F-09E6-4B99-90A3-E5B40E27A29EQ34465930-58BD6A12-4C63-4900-8165-3FDC3ECF2493Q34562734-6B50C1C9-21A3-437D-B2A4-AD05D0D619CCQ34583301-D6918E5E-7FA3-4438-B547-D25F32483C7CQ34718898-5BC45E30-8756-470A-81EC-E5CA1A59EB7DQ34978565-88FD91DC-C5C7-4B6E-86BB-A1547B2E59ABQ35155860-BE459A55-0739-4FB0-8AD5-7A28981D2642Q35171808-D47E1F0F-59ED-41B8-9CD8-90F36E6514E4Q35354031-9F7E311D-FDC2-417D-B1C4-7D4E7184AD24Q35360275-4404A2C8-098F-4B69-8373-46511EF79390Q35574993-34E4C60B-E5C3-4C03-ACAE-625654236357Q35594266-52352616-6DF3-4CF7-8D39-F6F9A61A4FF9Q35622197-8C7094FC-BB92-41B1-852D-24D48CFC5F7AQ35677048-34CB2BF6-1859-41E2-82A7-4A3C91CB9DA6Q35779468-D2DE10A0-606C-4492-8739-B7086FCDB4BEQ35807826-6989E50A-5981-4A45-8C2D-7AF5AF81D3BB
P2860
Intrasphincteric botulinum toxin for the treatment of achalasia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Intrasphincteric botulinum toxin for the treatment of achalasia.
@en
Intrasphincteric botulinum toxin for the treatment of achalasia.
@nl
type
label
Intrasphincteric botulinum toxin for the treatment of achalasia.
@en
Intrasphincteric botulinum toxin for the treatment of achalasia.
@nl
prefLabel
Intrasphincteric botulinum toxin for the treatment of achalasia.
@en
Intrasphincteric botulinum toxin for the treatment of achalasia.
@nl
P2093
P1476
Intrasphincteric botulinum toxin for the treatment of achalasia.
@en
P2093
P304
P356
10.1056/NEJM199503233321203
P407
P577
1995-03-01T00:00:00Z